| 741928 |
FRONTIERS IN ONCOLOGY |
Genetic Variants of CLPP and M1AP Are Associated With Risk of Non-Small Cell Lung Cancer |
2021-09-15 |
10.3389/fonc.2021.709829 |
Li Xianghan, Zou Yiran, Li Teng, Wong Thomas K. F., Bushey Ryan T., Campa Michael J., Gottlin Elizabeth B., Liu Hongliang, Wei Qingyi, Rodrigo Allen, Patz Edward F. |
| 741927 |
FRONTIERS IN ONCOLOGY |
Cascade Release Nanocarriers for the Triple-Negative Breast Cancer Near-Infrared Imaging and Photothermal-Chemo Synergistic Therapy |
2021-09-15 |
10.3389/fonc.2021.747608 |
Li Ke, Li Ruyue, Zhou Baona, Chen Jing, Lan Kai, Zhan Wenhua, Chen Di, Zhang Tao, Li Xueping |
| 741926 |
FRONTIERS IN ONCOLOGY |
Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms |
2021-09-15 |
10.3389/fonc.2021.762928 |
Lim Ken-Hong, Matsuura Shinobu, Xu Bing |
| 741925 |
FRONTIERS IN ONCOLOGY |
Editorial: Protein Functional Changes and Signaling Transduction in Cancer Stem Cells |
2021-09-15 |
10.3389/fonc.2021.761678 |
Tanabe Shihori |
| 741924 |
FRONTIERS IN ONCOLOGY |
Surgical Resection Is Still Better Than Endoscopic Resection for Patients With 2-5 cm Gastric Gastrointestinal Stromal Tumours: A Propensity Score Matching Analysis |
2021-09-15 |
10.3389/fonc.2021.737885 |
Wu Hao, Li Han, Xu Qinfeng, Shang Liang, Zhang Ronghua, Li Chen, Fu Mengdi, Xu Wandi, Chen Jianfeng, Liu Jin, Li Leping |
| 741923 |
FRONTIERS IN ONCOLOGY |
Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal Tumor |
2021-09-15 |
10.3389/fonc.2021.739134 |
Chen Meiting, Xue Cong, Huang Ri-qing, Ni Meng-qian, Li Lu, Li Hai-feng, Yang Wei, Hu An-qi, Zheng Zhou-san, An Xin, Shi Yanxia |
| 741922 |
FRONTIERS IN ONCOLOGY |
The Uniqueness of Clear Cell Renal Cell Carcinoma: Summary of the Process and Abnormality of Glucose Metabolism and Lipid Metabolism in ccRCC |
2021-09-15 |
10.3389/fonc.2021.727778 |
Qi Xiaochen, Li Quanlin, Che Xiangyu, Wang Qifei, Wu Guangzhen |
| 741921 |
FRONTIERS IN ONCOLOGY |
A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma |
2021-09-15 |
10.3389/fonc.2021.706915 |
Nie Ye, Li Jianhui, Wu Wenlong, Guo Dongnan, Lei Xinjun, Zhang Tianchen, Wang Yanfang, Mao Zhenzhen, Zhang Xuan, Song Wenjie |
| 741920 |
FRONTIERS IN ONCOLOGY |
Predicting Response to Systemic Chemotherapy for Advanced Gastric Cancer Using Pre-Treatment Dual-Energy CT Radiomics: A Pilot Study |
2021-09-15 |
10.3389/fonc.2021.740732 |
Liu Yi-yang, Zhang Huan, Wang Lan, Lin Shu-shen, Lu Hao, Liang He-jun, Liang Pan, Li Jun, Lv Pei-jie, Gao Jian-bo |
| 741919 |
FRONTIERS IN ONCOLOGY |
Immune-Related Adverse Events Associated With Outcomes in Patients With NSCLC Treated With Anti-PD-1 Inhibitors: A Systematic Review and Meta-Analysis |
2021-09-15 |
10.3389/fonc.2021.708195 |
Zhao Zhe, Wang Xinfeng, Qu Jinghan, Zuo Wei, Tang Yan, Zhu Huijuan, Chen Xiaoguang |
